Significance of peritoneal washing cytopathology in ovarian carcinomas and tumors of low malignant potential: A quality control study with literature review

Acta Cytologica

Volumn 55, Issue 1, 2010, Pages 57-68

  Özkara, Sevgiye Kaçar ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Borderline; Cytology; Cytopathology; Ovarian cancer; Peritoneal washing

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CELL DIFFERENTIATION; CYTOPATHOLOGY; DIAGNOSTIC PROCEDURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MEDICAL LITERATURE; OVARY CARCINOMA; PERITONEAL WASHING; PERITONEUM; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY;

EID: 79953774088     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000320858     Document Type: Article

References (31)

1. Fadare O, Mariappan MR, Wang S, Hileeto D, McAlpine J, Rimm DL. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings. Cancer 2004; 102: 150-156.
2. Zuna RE, Behrens A. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. J Natl Cancer Inst 1996; 88: 980-987.
3. Rubin S, Wong G, Curtin J, Barahat R, Hakes T, Hoskins W. Platinum-based chemotherapy of high risk stage I epithelial ovarian cancer following comprehensive surgical staging. Obstet Gynecol 1993; 82: 143-147.
4. Sharifi S, Ducatman BS, Wang HH, Fraser JL. Peritoneal washing cytology is unnecessary in gynecologic surgery for benign diseases. Cancer 1999; 87: 259-262.
5. Willett GD. Prognostic value of cytologic peritoneal washings. Clin Lab Med 1985; 5: 265-274.
6. Keetel WC, Elkins HB. Experience with radioactive colloidal gold in the treatment of ovarian cancer. Am J Obstet Gynecol 1956; 71: 553-568.
7. Creasman WT, Rutledge F. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 1971; 110: 773-781.
8. Colgan TJ, Boerner SL, Murphy J, Cole DE, Narod S, Rosen B. Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy. Gynecol Oncol 2002; 85: 397-403.
9. Fujiwara K, Yamauchi H, Yoshida T, Suzuki S, Oda T, Kohno I. Relationship between peritoneal washing cytology through implantable port system (IPS-cytology) and second-look laparotomy in ovarian cancer patients with unmeasurable residual diseases. Gynecol Oncol 1998; 70: 231-235.
10. Mulvany N. Cytohistologic correlation in malignant peritoneal washings: analysis of 75 malignant fluids. Acta Cytol 1996; 40. 1231-1239.
11. Ravinsky E. Cytology of peritoneal washings in gynecologic patients: diagnostic criteria and pitfalls. Acta Cytol 1986; 30: 8-16.
12. Yoshimura S, Scully RE, Taft PD, Herrington JB. Peritoneal fluid cytology in patients with ovarian cancer. Gynecol Oncol 1984; 17: 161- 167.
13. Rubin SC, Dulaney ED, Markman M, Hoskins WJ, Saigo PE, Lewis JL. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma. Obstet Gynecol 1988; 71: 851-853.
14. Mottolese M, Salzano M, Vincenzoni C, Benevolo M, Bigotti A, Iacovelli A, Lombardi A, Atlante G, Natali PG. The use of a panel of monoclonal antibodies can lower false-negative diagnoses of peritoneal washings in ovarian tumors. Cancer 1991; 68: 1803-1807.
15. Pretorius RG, Lee KR, Papillo J, Baker S, Belinson J. False-negative peritoneal cytology in metastatic ovarian carcinoma. Obstet Gynecol 1986; 618: 619-623.
16. Cheng L, Wolf NG, Rose PG, Rodriguez M, Abdul-Karim FW. Peritoneal washing cytology of ovarian tumors of low malignant potential: correlation with surface ovarian involvement and peritoneal implants. Acta Cytol 1998; 42: 1091-1094.
17. Ziselman EM, Harkavy SE, Hogan M, West W, Atkinson B. Peritoneal washing cytology: uses and diagnostic criteria in gynecologic neoplasms. Acta Cytol 1984; 28: 105-110.
18. Prat J. Serous borderline tumors of the ovary. Adv Clin Path 1997; 1: 97-102.
19. Mathew S, Erozan YS. Significance of peritoneal washings in gynecologic oncology: the experience with 901 intraoperative washings at an academic medical center. Arch Pathol Lab Med 1997; 121: 604-606.
20. Valente PT, Schantz HD, Edmonds PR, Hanjani P. Peritoneal cytology of uncommon ovarian tumors. Diagn Cytopathol 1992; 8: 98-106.
21. Zuna RE, Mitchell ML, Mulick KA, Weijchert WM. Cytohistologic correlation of peritoneal washing cytology in gynecologic disease. Acta Cytol 1989; 33: 327-336.
22. Lowe E, McKenna H. Peritoneal washing cytology: a retrospective analysis of 175 gynaecological patients. Aust NZ J Obstet Gynaecol 1989; 29: 55-61.
23. Cefis F, Forni A, Carinelli S, Cangini L. Significance of ascitic fluid and peritoneal washing cytology in ovarian tumor diagnosis. Tumori 1978; 64: 77-88.
24. Morton DG, Moore JG, Chang N. The clinical value of peritoneal lavage for cytologic examination. Am J Obstet Gynecol 1961; 81: 1115-1125.
25. Walts AE. Optimization of the peritoneal lavage. Diagn Cytopathol 1998; 18: 265-269.
26. Covell JL, Carry JB, Feldman PS. Peritoneal washings in ovarian tumors: potential sources of error in cytologic diagnosis. Acta Cytol 1985; 29: 310-316.
27. Zuna RE, Mitchell ML. Cytologic findings in peritoneal washings associated with benign gynecologic disease. Acta Cytol 1988; 32: 139-147.
28. Selvaggi SM. Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis. Diagn Cytopathol 2003; 28: 335-341.
29. Johnson TL, Kumar NB, Hopkins M, Hughes JD. Cytologic features of ovarian tumors of low malignant potential in peritoneal fluids. Acta Cytol 1988; 32: 513-518.
30. Barnhill DR, O'Connor DM. Management of ovarian neoplasms of low malignant potential. Oncology (Williston Park) 1991; 5: 21-26; discussion 26, 28, 31-32.
31. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary: a distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996; 20: 1319-1330.